BRIEF published on 05/20/2025 at 14:06, 1 year 5 months ago Philikos BV Initiates Phase 1/2 Trial of T-Guard® for Systemic Sclerosis Clinical Trial Philikos BV T-Guard® Systemic Sclerosis Autoimmune Disorder
PRESS RELEASE published on 05/20/2025 at 14:01, 1 year 5 months ago Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis Philikos initiates Phase 1/2 study with T-Guard in systemic sclerosis patients to evaluate safety and efficacy, aiming to offer a less invasive treatment option Clinical Trial Systemic Sclerosis Autoimmune Disorder Philikos T-Guard
Published on 11/10/2026 at 14:45, 6 hours 11 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 6 hours 25 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 6 hours 26 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 6 hours 26 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 6 hours 56 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 18:54, 2 hours 1 minute ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 2 hours 11 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 2 hours 26 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:20, 2 hours 35 minutes ago Edison issues report on Custodian Property Income REIT (LSE: CREI)
Published on 11/10/2026 at 17:31, 3 hours 24 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 6 hours 56 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 9 hours 53 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 13 hours 56 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 2 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
